Citations

Clear

55 citation(s) found for "Jentoft, Mark".

Recurrent Genomic Alterations in Soft Tissue Perineuriomas
Carter, Jodi M. , Wu, Yanhong , Blessing, Melissa M. , Folpe, Andrew L. , Thorland, Erik C., Spinner, Robert J. , Jentoft, Mark E. , Baheti, Saurabh , Niu, Zhiyv , Mauermann, Michelle L. , Mauermann, Michelle L , Niu, Zhiyv , Wang, Chen , Klein, Christopher J. , Carter, Jodi

Mayo Clinic

American Journal of Surgical Pathology | October 10, 2018 | Volume: 42 | Issue: 12 | Pages: 1708-1714

10.1097/pas.0000000000001169 | PMID 30303818 Get It

Perineuriomas are rare nerve sheath tumors, divided into intraneural and extraneural (soft tissue) types. Intraneural perineuriomas frequently contain TRAF7 mutations, and rarely, chr22q12 deletions. While chr22q losses can occur in soft tissue perineuriomas, comprehensive high-resolution molecular profiling has not been reported in these tumors and TRAF7 status is unknown. We used whole-exome sequencing and OncoScan single nucleotide polymorphism (SNP) array to evaluate 14 soft tissue perineuriomas. Thirteen cases showed 2 or more chromosomal abnormalities, composed primarily of large deletions. Recurrent chr22q deletions, containing the NF2 locus (n=6) and the previously unreported finding of chr17q deletions, with the NF1 locus (n=4) were frequent events and were mutually exclusive in all but1 case. In addition, 5 cases had varying chr2 deletions; and 4 cases had chr6 deletions. A chr10 deletion (previously reported in the sclerosing variant of soft tissue perineurioma) was observed in one case and another case had chr7 chromothripsis as the sole chromosomal abnormality. No TRAF7 mutations or alterations were identified in any case and no other evaluated gene (MAF<0.0001) had recurrent, deleterious mutations in >2 cases. The molecular genetic profiles showed no association with patient sex, age, tumoral histology or anatomic site. OncoScan SNP array analysis was performed on 10 cases and showed high concordance with the whole exome data, validating the large-scale deletions, duplications, and chr7 chromothripsis findings. In soft tissue perineuriomas, recurrent 22q12 deletions (with NF2) and 17q11 deletions (with NF1) appear to be mutually exclusive events, and alterations in NF1 or NF2 likely contribute to perineurioma pathogenesis, similar to other nerve sheath tumors. Moreover, the lack of TRAF7 mutations in soft tissue perineuriomas indicates divergent pathogenetic mechanisms from those of intraneural perineuriomas.
Sellar Region Atypical Teratoid/Rhabdoid Tumors in Adults: Clinicopathological Characterization of Five Cases and Review of the Literature
Paolini, Michael A., Kipp, Benjamin R. , Sukov, William R. , Jenkins, Sarah M. , Aranda, Derick, SantaCruz, Karen S., Al‐Dandan, Sadeq , Fisher, P. H., McDonald, William C. , Bondurant, Charles P., Darkow, G. V. D., Parisi, Joseph E. , Jentoft, Mark E. , Raghunathan, Aditya , Barr Fritcher, Emily G, Raghunathan, Aditya , Fritcher, Emily G. Barr , McDonald, William C, Giannini, Caterina

Mayo Clinic

Journal of Neuropathology & Experimental Neurology | October 5, 2018 | Volume: 77 | Issue: 12 | Pages: 1115-1121

10.1093/jnen/nly091 | PMID 30295777 Get It

Recurrent desmoid-type fibromatosis associated with underlying neuromuscular choristoma
Stone, Jonathan J. , Prasad, Nikhil K. , Howe, B. Matthew, Amrami, Kimberly K. , Carter, Jodi M. , Jentoft, Mark E. , Spinner, Robert J. , Laumonerie, Pierre , Carter, Jodi

Mayo Clinic

Journal of Neurosurgery | August 31, 2018 | Volume: 131 | Issue: 1 | Pages: 175-183

10.3171/2018.3.jns152935 | PMID 30168738 Get It

OBJECTIVEDesmoid-type fibromatosis (DTF) presents a therapeutic dilemma. While lacking metastatic potential, it is a locally aggressive tumor with a strong propensity for occurrence near nerve(s) and recurrence following resection. In this study, the authors introduce the association of an occult neuromuscular choristoma (NMC) identified in patients with DTF.METHODSAfter experiencing a case of DTF found to have an occult NMC, the authors performed a retrospective database review of all other cases of biopsy-proven DTF involving the extremities or limb girdles in patients with available MRI data. Two musculoskeletal radiologists with expertise in peripheral nerve imaging reviewed the MRI studies of the eligible cases for evidence of previously unrecognized NMC.RESULTSThe initial case of a patient with an occult sciatic NMC is described. The database review yielded 40 patients with DTF—18 (45%) in the upper limb and 22 (55%) in the lower limb. Two cases (5%) had MRI findings of NMC associated with the DTF, one in the proximal sciatic nerve and the other in the proximal tibial and sural nerves.CONCLUSIONSThe coexistence of NMC may be under-recognized in a subset of patients with extremity DTF. This finding poses implications for DTF treatment and the likelihood of recurrence after resection or biopsy. Further study may reveal crucial links between the pathogenesis of NMC and DTF and offer novel therapeutic strategies.
Tumor-Associated Macrophage Expression of PD-L1 Is Associated with Recurrence after Subtotal Resection of Vestibular Schwannoma
Perry, Avital , Graffeo, Christopher S. , Jentoft, Mark E. , Driscoll, Colin L. W., Neff, Brian, Carlson, Matthew L. , Celda, María Peris, Link, Michael J. , Carlstrom, Lucas P. , Raghunathan, Aditya , Neff, Brian A., Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | July 13, 2018 | Volume: 79 | Issue: S 01 | Pages: S1-S188

10.1055/s-0038-1633507 Get It

Skull Base Ebstein−Barr—s Virus−Associated Smooth Muscle Tumor in an 8-Year-Old Girl with CD4+ and CD8+ Lymphopenia
Deep, Nicholas L. , Driscoll, Colin L. W., Jentoft, Mark E. , Link, Michael J. , Daniels, David J., Brown, Desmond , Giannini, Caterina , Daniels, David J.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | July 13, 2018 | Volume: 79 | Issue: S 01 | Pages: S1-S188

10.1055/s-0038-1633639 Get It

Synchronous Epstein-Barr virus–associated skull base and adrenal smooth-muscle tumors in an 8-year-old girl with recent Epstein-Barr virus infection
Deep, Nicholas L. , Driscoll, Colin L. W., Link, Michael J. , Jentoft, Mark E. , Brown, Desmond , Daniels, David J.

Mayo Clinic

Journal of Neurosurgery: Pediatrics | June 15, 2018 | Volume: 22 | Issue: 3 | Pages: 283-287

10.3171/2018.3.peds17609 | PMID 29905497 Get It

Epstein-Barr virus–associated smooth-muscle tumors are rare tumors seen in immunocompromised patients. Most cases occur in the context of AIDS and organ transplantation, and very rarely in the setting of congenital immunodeficiency, with only 5 case reports of the latter published so far in the literature. The authors report the case of a previously healthy 8-year-old girl with headaches and precocious puberty who was found to have a large skull base lesion. There was a synchronous left adrenal lesion. She underwent resection of the skull base lesion and a left adrenalectomy. Thorough evaluation for immunodeficiency was negative for a known congenital immunodeficiency syndrome. She had a short course of intravenous immunoglobulin and has had no recurrence of disease or new lesions in the 17 months since presentation. Continued surveillance for the development of opportunistic infections and new or recurrent lesions is warranted in this case. Repeat surgery for surgically accessible tumors or chemoradiation would be recommended for any additional lesions.
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
Kurokawa, Cheyne, Iankov, Ianko, Anderson, S. Keith , Aderca, Ileana, Leontovich, Alexey A. , Oberg, Ann L. , Greiner, Suzanne , Becker, Marc A., Thompson, E. Aubrey , Haluska, Paul , Jentoft, Mark E. , Weroha, S. John , Jen, Jin , Iankov, Ianko D, Schroeder, Mark A. , Greiner, Suzanne M, Galanis, Evanthia , Maurer, Matthew J. , Giannini, Caterina , Parney, Ian F. , Sarkaria, Jann N.

Mayo Clinic

JNCI: Journal of the National Cancer Institute | March 6, 2018 | Volume: 110 | Issue: 10 | Pages: 1123-1132

10.1093/jnci/djy033 | PMID 29788332 Get It

Macrophage Density Predicts Facial Nerve Outcome and Tumor Growth after Subtotal Resection of Vestibular Schwannoma
Graffeo, Christopher S. , Perry, Avital , Raghunathan, Aditya , Kroneman, Trynda, Jentoft, Mark E. , Driscoll, Colin L. W., Neff, Brian, Carlson, Matthew L. , Jacob, Jeffrey T. , Link, Michael J. , Kroneman, Trynda N, Jentoft, Mark, Driscoll, Colin L., Raghunathan, Aditya , Neff, Brian A., Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2018 | Volume: 79 | Issue: 05 | Pages: 482-488

10.1055/s-0038-1627474 | PMID 30210976 Get It

Introduction Vestibular schwannoma (VS) behavior following subtotal resection (STR) is highly variable. Overall progression rates have been reported as high as 44%, and optimal treatment is controversial. Correspondingly, identification of a reliable clinical or pathologic marker associated with progression after STR would help guide decision-making. Methods A prospectively maintained institutional VS registry from 1999 to 2014 was retrospectively reviewed for sporadic VS patients who underwent primary STR without preceding stereotactic radiosurgery (SRS) by a single neurosurgery-neurotology team. Primary endpoints included tumor progression and postoperative facial nerve function. Pathologic specimens were stained for Ki67, CD68, S100, and SOX10 and were quantitated by digital imaging analysis. Macrophage density was defined as the ratio of CD68+ macrophages to S100+ macrophages and Schwannian tumor cells. Clinical outcomes were correlated with pathologic markers. Results Forty-six patients met the study inclusion criteria. Thirteen (28%) progressed during a mean 57 months of follow-up (range 15–149). Favorable postoperative facial nerve function (House–Brackmann I–II) was achieved in 37 (80%). CD68+ cells were present at significantly higher concentrations in tumors that progressed (p = 0.03). Higher macrophage density was significantly associated with both tumor progression (p = 0.02) and unfavorable facial nerve function (p = 0.02). Ki67 percent positivity was not significantly associated with either primary endpoint (p = 0.83; p = 0.58). Conclusions Macrophage density may provide an important marker for individuals at the highest risk for progression of VS after STR, potentially prompting closer surveillance or consideration for upfront SRS following STR. This finding supports preceding conclusions that an intratumoral macrophage-predominant inflammatory response may be a marker for tumor growth and a potential therapeutic target.
Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities
McDonald, Robert J. , Kallmes, David F. , Jentoft, Mark E. , Paolini, Michael A., Murray, David , Williamson, Eric E. , Eckel, Laurence J. , Murray, David L., McDonald, Jennifer S.

Mayo Clinic

Radiology | June 27, 2017 | Volume: 285 | Issue: 2 | Pages: 546-554

10.1148/radiol.2017161595 | PMID 28653860 Get It

Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates
McDonald, Robert J. , Schroeder, Dana , Jentoft, Mark E. , Murray, David , Kadirvel, Ramanathan , Eckel, Laurence J. , Kallmes, David F. , Dai, Daying , Murray, David L., McDonald, Jennifer S.

Mayo Clinic

Radiology | June 22, 2017 | Volume: 285 | Issue: 2 | Pages: 536-545

10.1148/radiol.2017161594 | PMID 28640692 Get It